ACHILLES THERAPEUTICS PLC's ticker is ACHL and the CUSIP is 00449L102. A total of 29 filers reported holding ACHILLES THERAPEUTICS PLC in Q3 2022. The put-call ratio across all filers is - and the average weighting 1.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $1,000 | – | 366 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 5,014,687 | $49,094,000 | 0.79% |
Boxer Capital, LLC | 1,536,016 | $15,038,000 | 0.53% |
Artal Group S.A. | 2,255,375 | $22,080,000 | 0.45% |
Redmile Group, LLC | 2,088,089 | $20,442,000 | 0.30% |
Affinity Asset Advisors, LLC | 80,000 | $783,000 | 0.28% |
SPHERA FUNDS MANAGEMENT LTD. | 292,194 | $2,861,000 | 0.19% |
Orbimed Advisors | 1,584,845 | $15,516,000 | 0.16% |
Baker Brothers Advisors | 2,591,366 | $25,369,000 | 0.11% |
Perceptive Advisors | 1,510,750 | $14,790,000 | 0.10% |
Monashee Investment Management LLC | 64,697 | $633,000 | 0.08% |